Federal preemie research law extended to 2029 with new mandates

What does this do?

HR 1197 renews the PREEMIE Act through 2029, continuing federal research programs on the causes, prevention, and care of premature and low birthweight births. The bill changes a prior optional provision to a firm requirement, directing the Department of Health and Human Services to establish an interagency working group on premature birth within 18 months. It also directs the National Academies of Sciences, Engineering, and Medicine to convene a maternal health expert panel and deliver a report to Congress within two years covering costs, risk factors, and early detection.

Who does it affect?

The bill primarily affects premature infants and their families, pregnant women at risk of early delivery, and medical and research professionals in maternal and infant health. It also shapes how federal health agencies allocate funding and direct their work.

Why does it matter?

Extending the law keeps federal research funding active and creates new accountability structures for how agencies coordinate on premature birth. The required study and working group may influence future policy, spending priorities, and clinical practice in maternal and infant health.

What does it cost, and who pays?

• Federal research funding extended to 2029
• No direct payments to families
• No insurance rule changes

Where does it stand?